AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

Clinical trial NCT06959524 · RECRUITING

Trial details

NCT number: NCT06959524
Sponsor: Boston Scientific Corporation
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Coronary Arterial Disease (CAD)de Novo Lesions in Native Coronary Arteries

Start date: 2025-08-21
Primary completion: 2028-03-01
Enrollment: 1616

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.